This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
.” It is still an oddity in Australia but in many US states, medicinal cannabis medications including tetrahydrocannabinol (THC) — the psychoactive component in cannabis — are being used as a treatment for pets with conditions such as arthritis and epilepsy. It is a big and growing business.
The Current Treatments for Autism. Most education-based autism treatment is focused on teaching developing children self-care, communicative, and social skills. Most education-based autism treatment is focused on teaching developing children self-care, communicative, and social skills. Instead, CBD is being used.
GW Pharmaceuticals created the medication after studies showed surprising success treating severe childhood epilepsy, specifically Lennox-Gastaut Syndrome and Dravet Syndrome. Now, Marijuana Business Daily reports that the European Commission has just approved the drug as well. Thanks to these observations in the U.S. In the U.S.,
A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals. CBD-based treatment for people with Refractory Epilepsy?—?is Refractory Epilepsy is epilepsy that involves frequent and severe seizures that are difficult to treat. CannEpil™?—?CBD-based
and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. –(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., Under the Leadership of Nicolas Schlienz, Ph.D., COLORADO SPRINGS, Colo.–(BUSINESS
A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals Right now in Australia, access to Cannabis-based treatments is heavily restricted. Physicians who want to prescribe Medicinal Cannabis are required to jump through countless regulatory hoops, as are patients seeking treatment.
She came to the industry not from the recreational side, but as a mother seeking treatment for her child with epilepsy. In 2014, I was reading the Senate Bill 339 [Texas’ Compassionate Use Act enacted in 2015] testimony of mothers of children with epilepsy. My own daughter had seizures when she was little.
Fortunately, at MGC Pharma, we are in the business of Medical Cannabis and have spent years researching and understanding the effects and phenotypes of different strains to determine which ones work best for different conditions, with each containing different amounts of THC, CBD and other components. You can learn more about it here.
DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. This Epilepsy – Pipeline Insight, 2021 provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Epilepsy pipeline landscape.
Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy. It is also alleged that the unlawful advertising included unapproved references to the treatment of serious diseases or conditions, including in some cases cancer and epilepsy.
By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. New businesses have emerged, and existing companies have expanded to support the industry’s various needs. This economic boost goes beyond the industry itself.
BOSTON–(BUSINESS WIRE)– #ANXIETY–Quolet, a private clinical stage biopharmaceutical company, is announcing the completion of a Phase 1 healthy volunteer study evaluating pure Cannabidiol (CBD) (clinicaltrials.gov NCT05032807).
Are you considering getting into the growing and/or selling business and want to know how to promote your products to your customers? Assisted Cancer Treatment. It can help to reduce the amount of nausea that patients may feel after chemotherapy treatments. Throughout the U.S.,
European Cannabis Business News and Updates for This Week. With 19 licensed importers in Germany in the meanwhile, this represents an necessary time within the development of the nation’s medical cannabis business. Epidiolex is an epilepsy-fighting cannabis base drug produced by GW Prescription drugs.
There are two main sections to the reform, one for businesses and the second for patients: Reform to cannabis business licensing process: The licensing process for cannabis research institutes and cannabis dispensing pharmacies expanded and clarified. This permit encompasses business planning and development pending final approval.
House Bill 136 was overwhelmingly approved in a vote of 16 to one after committee members heard from constituents who suffer from health problems such as epilepsy and chronic pain. Farmers could apply for a license to cultivate the crop, and processors, retailers, and labs testing facilities could also apply for separate business licenses.
–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. Extended Duration Safety and Efficacy of Adjunctive Ganaxolone Treatment in Patients with CDKL5 Deficiency Disorder: 8-Month Minimum Open-Label Extension Follow-up. at the end of the 17 weeks of ganaxolone treatment. RADNOR, Pa.–(BUSINESS
Businesses want to broaden their advertising strategy now that it has touched the neighborhoods. Full spectrum distillate is being used to treat anything from muscular pains and anxiety to arthritis, epilepsy, and PTSD. Full-spectrum products have also been used for stress alleviation and pain treatment. Final Thoughts.
.–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. We look forward to initiating our Phase 3 trial and adding to the body of evidence that supports ganaxolone’s potential as an innovative treatment option for rare epilepsies.”. Chief Medical Officer of Marinus. “We Data Highlights.
A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy.
If until recently working with cannabis was taboo for law firms, having experience in this niche today has become a lure of clients and new business opportunities as interesting as opening up an incipient sector with the potential to move millions of reais in the Brazil in the coming years.
drug regulators approved the first marijuana-based pharmaceutical to treat kids with a form of epilepsy, and billions of investment dollars poured into cannabis companies. It’s a non-psychoactive compound found in marijuana and hemp plants and used for treatment of certain medical problems. It’s not just the U.S.
Apart from business leaders, many corporate and government institutions are funding the research and development of cannabinoids for medical applications,” reads an excerpt from the report. The report authors noted that THC, on the other hand, is touted as a popular option for alleviating the negative effects of AIDS and cancer treatment.
The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.
–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. Nanomerics”) to use Nanomeric’s molecular envelope platform technology (MET) for the nasal delivery of a cannabidiol (CBD) for the management of epilepsy in adults and children. Nanomerics has initiated preclinical studies of VRP324.
Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. The Georgia State Board of Pharmacy recently made the decision to endorse more cannabis oil sale outlets.
As per the proposed bill, multiple sclerosis (MS), Parkinson’s disease , epilepsy , post-traumatic stress disorder (PTSD), and HIV/AIDS are some examples of medical conditions featured on the list of qualifying criteria. North Carolina Ought to Catch Up with the Rest of the U.S. by 2024.
DUBLIN–(BUSINESS WIRE)–The “Medical Cannabis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has been added to ResearchAndMarkets.com’s offering. Cannabis is safer and has less severe side effects in comparison to other treatment options. during 2021-2026.
Business Cann first reported on the development of the ‘Patient Registry for Cannabis-Based Products’, last year and the NHS has confirmed it will launch on April 1. ( He would like to see the registry opened up to the private sector and believes the restricted conditions available for treatment through the NHS will limit its effectiveness.
DUBLIN–(BUSINESS WIRE)–The “Global Legal Cannabis Market 2021-2028” report has been added to ResearchAndMarkets.com’s offering. Thus, a wide application scope has led to an increased product demand for the treatment of various chronic conditions. billion by 2028, registering a CAGR of 26.3% Medical Use.
The passage of the 2018 Farm Bill and the legalization of hemp and hemp-derived products has sparked strong business interest from foreign stakeholders. This blog posts briefly addresses the risks and feasibility of engaging in this business at the moment. IMPORTING HEMP.
A Business World reporter quoted that Duterte had said “Marijuana – they are cultivated…I’ll give you the excuse to harvest for… they will say it’s medicinal. This probably inspired the approval on the third and final reading of House Bill (HB) No. 6517 (Philippine Compassionate Medical Cannabis Act). Everything is medicinal.
Acne Treatment. For sufferers of neurological ailments such as epilepsy and multiple sclerosis, an oral spray containing CBD can help to reduce the intensity and regularity of symptoms such as muscle spasms and seizures due to its effect on the ECS and other receptors that send signals to and from the brain. .
Due to the growing popularity and mainstream nature of CBD-infused products, many alcohol beverage companies were surprised to read us conclude that blending CBD into their products was a risky business, even in hemp-friendly states like Oregon. As we have discussed at length since the enactment of the 2018 Farm Bill (e.g.,
iii] The Act was originally intended for patients with intractable epilepsy and was expanded in 2019 and 2021 to include other physical and mental illnesses (cancer, multiple sclerosis, post-traumatic stress disorder). [iv] Specifically, H.B.
The fulfilment, which has been prescribed to Jorja Emerson, a three-year-old British girl who suffers from severe epilepsy, demonstrates a real progression in the quest to allow patients to access pioneering treatments of Medical Cannabis. Cannaray today announces the fulfilment of its first Medical Cannabis prescription in the UK.
As Missouri’s medical marijuana program matured, the number of licensed businesses and registered patients continued to grow. Eligibility hinges on qualifying conditions, ranging from chronic pain to epilepsy. Guardians or parents can apply on behalf of minors in need of treatment.
Although there is no excise tax on medical cannabis, there is a medical cannabis special privilege tax of 4% of the gross receipts or gross proceeds derived from the sale of usable cannabis to be collected by cultivation facilities, dispensaries, or other cannabis businesses and remitted to the Department of Finance and Administration.
This rare type of epilepsy caused her to endure up to 300 grand mal seizures per week from the tender age of five. After exhausting alternative treatment options, her mother Paige desperately started looking for a way to improve Charlotte’s quality of life.
DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. However, no single cannabinoid drug has received widespread approval in the treatment of pain. However, regulations are constantly shifting.
However, the Lone Star State could make significant progress toward expanding the Compassionate Use Program and putting medical treatment choices for certain medical conditions into the hands of medical providers and patients rather than politicians. Currently, only epilepsy patients may use the drug produced at three state facilities.
Due to the growing popularity and mainstream nature of CBD-infused products, many alcohol beverage companies were surprised to read us conclude that blending CBD into their products was a risky business, even in hemp-friendly states like Oregon. As we have discussed at length since the enactment of the 2018 Farm Bill (e.g.,
Home cannabis cultivation is not allowed, however, if the person has less than 5 plants, “it will be assumed that there is no question of any professional trade or business being conducted,” according to the government of the Netherlands. In 2003, the Netherlands legalized medical cannabis.
This National Epilepsy Awareness Month, TXOG advocates for the power of medical cannabis for epilepsy patients. Diagnosed with epilepsy at 3 years old, Ortiz would experience erratic, unpredictable seizure clusters, each lasting 20 minutes.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content